Market News AIOpen the app

Alzamend Neuro is planning to sell up to 39.36 million shares owned by its stockholders.

New sharesRead the original at streetinsider.com
Bad for ALZN

Alzamend filed for current holders to sell up to 39.36 million shares. Possible sales could weigh on its stock, but no sale is confirmed and Alzamend gets no proceeds.

ALZN · Alzamend Neuro, Inc.

AI read · Bad for ALZN

The AI's read

The filing would not bring cash to Alzamend because current holders, not the company, would receive any sale money. If holders sell, more shares could be offered to buyers, which may weigh on the stock. The filing does not say how many shares will actually be sold.

Get alerts for ALZN

Follow Alzamend Neuro, Inc. (ALZN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ALZN
Free on the App Store and Google Play, or on the web.